Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Jantus-Lewintre, E; Sureda, BM; Larriba, JLG; Rodriguez-Abreu, D; Juan, O; Blasco, A; Domine, M; Pulla, MP; Garde, J; Alvarez, R; Maestu, I; de Carrion, RP; Artal, A; Rolfo, C; de Castro, J; Guillot, M; Oramas, J; de las Penas, R; Ferrera, L; Martinez, N; Serra, O; Rosell, R; Camps, C; Grp Espanol Canc Pulmon GECP.

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

Frontiers in Oncology. 2021; 11: 695038-695038 Nº de citas: 7 [doi:10.3389/fonc.2021.695038]

Provencio, M; Gallego, JMM; Calles, A; Antonanzas, M; Pangua, C; Rubio, XM; Nadal, E; Castro, RL; Lopez-Martin, A; Del Barco, E; Domine, M; Franco, F; Diz, P; Sandoval, C; Girona, ES; Sullivan, I; Sala, MA; Ledo, GG; Cucurull, M; Mosquera, J; Martinez, M; Chara, LE; Arriola, E; Herrera, BE; Jarabo, JR; Alvarez, RA; Baena, J; Cao, MG.

Lung cancer patients with COVID-19 in Spain: GRAVID study

LUNG CANCER. 2021; 157: 109-115 Nº de citas: 30 [doi:10.1016/j.lungcan.2021.05.014]

Curigliano, G; Martin, M; Jhaveri, K; Beck, JT; Tortora, G; Fazio, N; Maur, M; Hubner, RA; Lahner, H; Donnet, V; Ajipa, O; Li, Z; Blumenstein, L; Andre, F.

Clinical Trial

EUROPEAN JOURNAL OF CANCER. 2021; 151: 49-62 Nº de citas: 22 [doi:10.1016/j.ejca.2021.03.042]

Aviles-Izquierdo, JA; Mercader-Cidoncha, E; Escat-Cortes, JL; Marquez-Rodas, I; Parra-Blanco, V; Rodriguez-Lomba, E.

When is it worth performing lymphadenectomy in patients with melanoma micrometastases? A 20-year experience retrospective analysis

Cirugia y Cirujanos. 2021; 89(4): 457-460 Nº de citas: 1 [doi:10.24875/CIRU.20000545]

Johnston, S; O'Shaughnessy, J; Martin, M; Huober, J; Toi, M; Sohn, J; Andre, VAM; Martin, HR; Hardebeck, MC; Goetz, MP.

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups

npj Breast Cancer. 2021; 7(1): 80-80 Nº de citas: 54 [doi:10.1038/s41523-021-00289-7]

Romera, A; Cebollero, M; Romero-Gomez, B; Carricondo, F; Zapatero, S; Garcia-Aldao, U; Martin-Albo, L; Ortega, J; Vara, E; Garutti, I; Simon, C.

Effect of Intravenous Lidocaine on Inflammatory and Apoptotic Response of Ischemia-Reperfusion Injury in Pigs Undergoing Lung Resection Surgery

Biomed Research International. 2021; 2021: 6630232-6630232 Nº de citas: 9 [doi:10.1155/2021/6630232]

Aapro, M; Scotte, F; Escobar, Y; Celio, L; Berman, R; Franceschetti, A; Bell, D; Jordan, K.

Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data

ONCOLOGIST. 2021; 26(6): 1073-1082 Nº de citas: 45 [doi:10.1002/onco.13716]

Kuemmel, S; Tondini, CA; Abraham, J; Nowecki, Z; Itrych, B; Hitre, E; Karaszewska, B; Juarez-Ramiro, A; Morales-Vasquez, F; Perez-Garcia, JM; Cardona-Huerta, S; Monturus, E; Sequi, M; Restuccia, E; Benyunes, M; Martin, M.

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

BREAST CANCER RESEARCH AND TREATMENT. 2021; 187(2): 467-476 Nº de citas: 18 [doi:10.1007/s10549-021-06145-3]

Garcia-Pardo, M; Ortega, L; Fernandez-Acenero, MJ; Alfonso, PG; Martin, M; Munoz, AJ.

Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study

Journal of Gastrointestinal Cancer. 2021; 52(2): 814-818 Nº de citas: 4 [doi:10.1007/s12029-021-00622-0]

Barca-Hernando, M; Munoz-Martin, AJ; Rios-Herranz, E; Garcia-Escobar, I; Beato, C; Font, C; Oncala-Sibajas, E; Revuelta-Rodriguez, A; Areses, MC; Rivas-Jimenez, V; Ballaz-Quincoces, A; Moreno-Santos, MA; Lopez-Saez, JB; Gallego-Gallego, I; Elias-Hernandez, T; Asensio-Cruz, MI; Chasco-Eguilaz, L; Garcia-Gonzalez, G; Estevez-Garcia, P; Marin-Barrera, L; Otero-Candelera, R; Lopez-Ruz, S; Lima-Alvarez, J; Sanchez-Diaz, JM; Real-Dominguez, M; Borrego-Delgado, MC; Marin-Romero, S; Jara-Palomares, L.

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

Cancers. 2021; 13(11): Nº de citas: 9 [doi:10.3390/cancers13112517]

Gonzalez-Senac, NM; Mayordomo-Cava, J; Macias-Valle, A; Aldama-Marin, P; Gonzalez, SM; Arnes, MLC; Jimenez-Gomez, LM; Vidan-Astiz, MT; Serra-Rexach, JA.

Colorectal Cancer in Elderly Patients with Surgical Indication: State of the Art, Current Management, Role of Frailty and Benefits of a Geriatric Liaison

International Journal of Environmental Research and Public Health. 2021; 18(11): Nº de citas: 29 [doi:10.3390/ijerph18116072]

Esteban, E; Exposito, F; Crespo, G; Lambea, J; Pinto, A; Puente, J; Arranz, JA; Redrado, M; Rodriguez-Antona, C; de Andrea, C; Lopez-Brea, M; Redin, E; Rodriguez, A; Serrano, D; Garcia, J; Grande, E; Castellano, D; Calvo, A.

Circulating Levels of the Interferon-gamma-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy

Cancers. 2021; 13(11): Nº de citas: 15 [doi:10.3390/cancers13112849]

Gyawali, B; de Vries, EGE; Dafni, U; Amaral, T; Barriuso, J; Bogaerts, J; Calles, A; Curigliano, G; Gomez-Roca, C; Kiesewetter, B; Oosting, S; Passaro, A; Pentheroudakis, G; Piccart, M; Roitberg, F; Tabernero, J; Tarazona, N; Trapani, D; Wester, R; Zarkavelis, G; Zielinski, C; Zygoura, P; Cherny, NI.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

ESMO Open. 2021; 6(3): 100117-100117 Nº de citas: 59 [doi:10.1016/j.esmoop.2021.100117]

Hamilton, E; Cortes, J; Ozyilkan, O; Chen, SC; Petrakova, K; Manikhas, A; Jerusalem, G; Hegg, R; Huober, J; Chapman, SC; Lu, Y; Hardebeck, MC; Bear, MM; Johnston, EL; Martin, M.

nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer

Clinical Breast Cancer. 2021; 21(3): 181 Nº de citas: 36 [doi:10.1016/j.clbc.2020.09.011]

Illini, O; Hochmair, MJ; Fabikan, H; Weinlinger, C; Tufman, A; Swalduz, A; Lamberg, K; Hashemi, SMS; Huemer, F; Vikstrom, A; Wermke, M; Absenger, G; Addeo, A; Banerji, S; Calles, A; Clarke, S; Di Maio, M; Durand, A; Duruisseaux, M; Itchins, M; Kaaranien, OS; Krenn, F; Laack, E; de Langen, AJ; Mohorcic, K; Pall, G; Passaro, A; Prager, G; Rittmeyer, A; Rothenstein, J; Schumacher, M; Woll, E; Valipour, A.

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Therapeutic Advances in Medical Oncology. 2021; 13: Nº de citas: 44 [doi:10.1177/17588359211019675]

Bellmunt, J; Esteban, E; Muro XGD; Sepulveda, JM; Maroto, P; Gallardo, E; Alba AGD; Etxaniz, O; Guix, M; Larriba JLG; Arranz, JA; Redrado, M; Calvo, A.

Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

European Urology Oncology. 2021; 4(3): 502-505 Nº de citas: 6 [doi:10.1016/j.euo.2019.07.014]

Escudero-Vilaplana, V; Collado-Borrell, R; Villanueva-Bueno, C; Alvarez, R; Herranz, A; Sanjurjo, M.

Acute pancreatitis in a patient treated with imatinib and gefitinib

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(4): 980-983 Nº de citas: 3 [doi:10.1177/1078155220949639]

Garcia-Martin, E; Escudero-Vilaplana, V; Fox, B; Collado-Borrell, R; Marzal-Alfaro, B; Sanchez-Isac, M; Solano-Garzon, ML; del Val, RG; Cano-Gonzalez, JM; de Lucas, NP; Bravo-Guillen, AI; Valero-Salinas, J; Gonzalez-Haba, E; Sanjurjo, M; Martin, M.

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

SUPPORTIVE CARE IN CANCER. 2021; 29(6): 3121-3127 Nº de citas: 8 [doi:10.1007/s00520-020-05828-9]